Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$17.49 USD
+0.17 (0.98%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $17.48 -0.01 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth F Momentum C VGM
Income Statements
Fiscal Year end for ORTHOFIX MEDICAL INC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 747 | 461 | 464 | 407 | 460 |
Cost Of Goods | 260 | 124 | 115 | 102 | 101 |
Gross Profit | 486 | 337 | 350 | 305 | 359 |
Selling & Adminstrative & Depr. & Amort Expenses | 625 | 350 | 358 | 311 | 378 |
Income After Depreciation & Amortization | -139 | -13 | -8 | -6 | -19 |
Non-Operating Income | -1 | -3 | -3 | 8 | -8 |
Interest Expense | 9 | 1 | 2 | 2 | 0 |
Pretax Income | -149 | -18 | -14 | 0 | -27 |
Income Taxes | 3 | 2 | 25 | -3 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -151 | -20 | -38 | 3 | -28 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -151 | -20 | -38 | 3 | -28 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -43 | 19 | 37 | 28 | 10 |
Depreciation & Amortization (Cash Flow) | 97 | 32 | 45 | 34 | 28 |
Income After Depreciation & Amortization | -139 | -13 | -8 | -6 | -19 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 36.70 | 20.10 | 19.69 | 19.39 | 18.90 |
Diluted EPS Before Non-Recurring Items | -4.12 | 0.30 | 0.86 | 0.26 | 1.47 |
Diluted Net EPS (GAAP) | -4.12 | -0.98 | -1.95 | 0.13 | -1.51 |
Fiscal Year end for ORTHOFIX MEDICAL INC falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 198.62 | 188.61 | 200.42 | 184.01 | 187.02 |
Cost Of Goods | 63.87 | 61.37 | 63.79 | 64.24 | 67.47 |
Gross Profit | 134.75 | 127.24 | 136.63 | 119.76 | 119.55 |
SG&A, R&D, and Dept/Amort Expenses | 159.66 | 156.58 | 154.94 | 144.21 | 156.18 |
Income After SG&A, R&D, and Dept/Amort Expenses | -24.91 | -29.34 | -18.31 | -24.45 | -36.63 |
Non-Operating Income | -2.51 | -1.27 | 0.77 | -2.36 | -0.02 |
Interest Expense | 4.94 | 4.56 | 4.50 | 1.58 | 1.27 |
Pretax Income | -32.36 | -35.17 | -22.05 | -28.39 | -37.92 |
Income Taxes | 1.08 | 0.85 | 0.12 | 0.47 | 1.51 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -33.44 | -36.02 | -22.17 | -28.86 | -39.43 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -33.44 | -36.02 | -22.17 | -28.86 | -39.43 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 38.00 | 37.70 | 37.30 | 37.20 | 36.80 |
Diluted EPS Before Non-Recurring Items | -0.88 | -0.95 | -0.59 | -0.77 | 0.02 |
Diluted Net EPS (GAAP) | -0.88 | -0.95 | -0.57 | -0.77 | -1.07 |